老年人使用大麻可能是发生机动车事故的重要且未被充分认识到的危险因素
Godfrey D Pearlson1,2, Deepak C D'Souza1, Richard A Marottoli1,3
1Yale University School of Medicine, New Haven, Connecticut, USA.
Cannabis and cannabinoid research
|December 30, 2025
概括
年龄较大的司机面临着因老龄化和大麻使用而增加的风险. 需要研究大麻中的delta-9四大麻 (THC) 如何影响高级驾驶员.
科学领域:
- 老年学是指老年学的学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 在美国,65岁以上的成年人越来越多,其中许多人是活跃的司机.
- 老龄化可能会对驾驶能力产生负面影响,认知能力下降和痴呆症加剧风险.
- 年长的司机每行驶一英里就会出现较高的撞车率和受伤严重程度.
研究的目的:
- 为了强调老年人越来越多地使用大麻.
- 检查与老年司机大麻使用相关的潜在风险.
- 为了强调缺乏关于这一特定人口和物质的研究.
主要方法:
- 文献综述和综合现有关于衰老,驾驶和大麻的研究.
- 对delta-9四化甘醇 (THC) 的生理和神经认知影响的分析.
- 检查影响大麻损伤的与年龄相关的药理动力学和药理动力学变化.
主要成果:
- 大麻,主要是由于THC,损害了安全驾驶必不可少的感官和神经认知功能.
- 急性大麻使用与机动车事故增加有关,包括致命事故.
- 老年人可能更容易受到大麻损伤,原因是代谢变化和与年龄有关的神经认知变化.
结论:
- 使用大麻的老司机可能面临着显著增加的机动车辆事故的风险.
- 关于大麻对老年人驾驶能力的影响的研究存在关键差距.
- 迫切需要增加注意力和公共卫生信息,以解决这一新出现的安全问题.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
201
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
201
Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
646
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
646
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
724
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
724
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
176
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
176


